Filing Details
- Accession Number:
- 0000950170-24-046887
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-04-23 16:05:49
- Reporting Period:
- 2024-04-18
- Accepted Time:
- 2024-04-23 16:05:49
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1850270 | Prokidney Corp. | PROK | Biological Products, (No Disgnostic Substances) (2836) | 981586514 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1936228 | J. Darin Weber | C/O Prokidney Corp 2000 Frontis Plaza Blvd, Suite 250 Winston-Salem NC 27103 | Svp Of Regulatory Development | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Ordinary Shares | Disposition | 2024-04-18 | 800 | $2.54 | 171,632 | No | 4 | S | Direct | |
Class A Ordinary Shares | Disposition | 2024-04-22 | 16,438 | $2.51 | 155,194 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.50 to $2.55, inclusive. The reporting person undertakes to provide to ProKidney Corp., any security holder of ProKidney Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The reported sale of shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2023.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.50 to $2.53, inclusive. The reporting person undertakes to provide to ProKidney Corp., any security holder of ProKidney Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.